Clinical Trials Directory

Trials / Unknown

UnknownNCT04784468

DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients

DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients Compared to Healthy Controls: A Case-control Study

Status
Unknown
Phase
Study type
Observational
Enrollment
135 (estimated)
Sponsor
University of Vienna · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic challenging health systems worldwide. While there is a clear correlation between oxidative stress markers and the severity of many viral diseases such as hepatitis C, for SARS-CoV clinical data is limited. The investigators aim at 1.) investigating DNA damage, oxidative stress, inflammation, and aging markers in COVID-19 patients and compare them with age and gender matched healthy controls and patients with influenza; and 2.) investigating all aforementioned parameters during "cytokine storm" via repeated blood sampling.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionCase-control design, one single investigation

Timeline

Start date
2020-11-19
Primary completion
2021-03-31
Completion
2021-09-30
First posted
2021-03-05
Last updated
2021-03-09

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT04784468. Inclusion in this directory is not an endorsement.